Drug Trial Radar · NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Jun 3, 2026
Primary completion
Jul 8, 2033
Study completion Jul 8, 2033
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jun 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.
Conditions
- Rheumatoid Arthritis
Interventions
AfimkibartDrug
Participants will receive Afimkibart as per the schedule mentioned in the protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Adverse Events (AEs)Time frame: From Baseline up to 6 years
Locations
17 sites in 5 countries. Site status is shown where the registry gives one.
Arthritis and Rheumatic Disease Specialty Inc
Tamarac, Florida · Recruiting
Accurate Clinical Research Inc.
Lake Charles, Louisiana · Recruiting
Accurate Clinical Management LLC
Houston, Texas · Recruiting
DM Clinical Research at Tomball
Tomball, Texas · Recruiting
Rheumatic Disease Center
Glendale, Wisconsin · Recruiting
Centro Medico Arsema
CABA, Buenos Aires, Argentina · Recruiting
APRILLUS Asistencia e Investigacion
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina · Recruiting
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso
Cuiab, Mato Grosso, Brazil · Recruiting
Centro Mineiro de Pesquisa - CMIP
Juiz de Fora, Minas Gerais, Brazil · Recruiting
CEPIC - Centro Paulista de Investigao Clnica e Servios Mdicos
São Paulo, São Paulo, Brazil · Recruiting
Nzoz Bif-Med
Bytom, Poland · Recruiting
Centrum Kliniczno-Badawcze J. Brzezicki, B. Górnikiewicz-Brzezicka Lekarze Spó?ka Partne
Elblag, Poland · Recruiting
Zespol Poradni Specjalistycznych REUMED filia nr 1 Wallenroda
Lublin, Poland · Recruiting
Twoja Przychodnia NCM
Nowa Sól, Poland · Recruiting
Reumatop Grzegorz Rozumek Karin Pistorius Spolka Jawna
Wroclaw, Poland · Recruiting
Centrum Medyczne Reuma Park
Warsaw, Masovian Voivodeship, Poland · Recruiting
Hospital Universitario Virgen Macarena
Seville, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.